ImmunoBiotics, Inc.
ImmunoBiotics, Inc. (IMBI) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 61 transactions totaling $9.2M, demonstrating a bullish sentiment with $9.1M in net insider flow. The most recent transaction on Jan 30, 2023 involved a transaction of 181,902 shares valued at $0.
IMBI Insider Activity Summary
Who Is Buying IMBI Stock?
No significant insider buying has been recorded for IMBI in the recent period.
Who Is Selling IMBI Stock?
No significant insider selling has been recorded for IMBI in the recent period.
Is ImmunoBiotics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IMBI is bullish with an Insider Alignment Score of 99/100 and a net flow of $9.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
IMBI Frequently Asked Questions
Understanding IMBI Insider Activity
Insider trading at ImmunoBiotics, Inc. (IMBI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading IMBI stock, having executed 61 transactions in the past 90 days. The most active insider is Eyal Lalo (Executive), who has made 8 transactions totaling $11.3M.
Related Tools
Track ImmunoBiotics, Inc. Insider Activity
Get notified when executives and directors at IMBI file new Form 4 transactions